Digital transformation in biopharma

Would you like to have a view into key trends in the space of digital transformation and omnichannel excellence? Participate now in the Across Health’s Maturometer survey!

For the last 13 years, Across Health (a global omnichannel engagement leader) has fielded the Maturometer, the most widely referenced research on the state of omnichannel in the life sciences.

The 2021 Maturometer is structured in line with Gleicher’s formula for change, which states you need 4 key drivers for successful change and transformation (burning platform/strategy/capabilities/early tangible initiatives). If one of them is missing, the result of any change/transformation effort will be suboptimal.

We would love to invite you to participate in this year’s Maturometer survey.

Here’s what you need to know:

  • The survey allows you to measure & benchmark your company’s digital maturity
  • It’s free & only takes 15-20 min of your time
  • Upon completion, you will get a report on how your company’s digital transformation benchmarks against biopharma competitors

Take the survey now.

This level of insight into the state of digital transformation at top pharma companies is a great tool to have as you enter the 2022 planning season.

The survey closes on July 10 – if you have time, we suggest you start NOW!


“Every day we are working towards changing the standard of care for both patients and HCPs. Not everyone can say they help to change lives in their job, and I am proud to say we do!”

Beginning May 20, 2024, the Precision Value & Health family of brands is becoming Precision AQ.

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include:
  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights. To find out more about our global services and our unified mission, to empower access to life-changing medicines for all, visit: Precision AQ

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.